WASHIGTON DC – President Trump is likely to loosen long-standing federal restrictions on marijuana early next year by reclassifying the drug under federal law, according to Axios. If that happens, the move would carry major consequences for cannabis companies, investors, researchers, and state-regulated marijuana markets.

Under the plan under review, marijuana would be shifted from Schedule I — a category reserved for drugs like heroin that are deemed to have no accepted medical use — to Schedule III, a classification that recognizes medical value and lower abuse potential. While the change would stop short of fully legalizing marijuana at the federal level, it would significantly reshape the cannabis industry’s financial and regulatory landscape.

Why the Change Matters

Reclassifying ma

See Full Page